Avinger to Announce Fourth Quarter and Full Year 2018 Financial Results on March 6, 2019
February 28, 2019 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided,...
Avinger’s Pantheris SV (Small Vessel) Featured in Live Case Transmission at Leipzig Interventional Course (LINC) 2019
January 28, 2019 08:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its...
Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device
December 13, 2018 07:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that...
Avinger Announces Commercial Launch in Australia
December 06, 2018 08:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company that designs and develops the first-ever image-guided, catheter-based...